{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:52:18Z","timestamp":1774263138412,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jaac.2021.05.025","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T21:02:34Z","timestamp":1625173354000},"page":"354-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antipsychotics in Children and Adolescents at Clinical High Risk for Psychosis"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3709-4111","authenticated-orcid":false,"given":"Andrea","family":"Raballo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3306-8197","authenticated-orcid":false,"given":"Michele","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9003-9838","authenticated-orcid":false,"given":"Antonio","family":"Preti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2021.05.025_bib1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00787-020-01488-6","article-title":"Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence","volume":"29","author":"Dinnissen","year":"2020","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.05.025_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaac.2016.12.013","article-title":"Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis","volume":"56","author":"Pagsberg","year":"2017","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.05.025_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.eurpsy.2015.01.013","article-title":"EPA guidance on the early intervention in clinical high risk states of psychoses","volume":"30","author":"Schmidt","year":"2015","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jaac.2021.05.025_bib4","series-title":"Guidance: psychosis and schizophrenia in adults","year":"2014"},{"key":"10.1016\/j.jaac.2021.05.025_bib5","doi-asserted-by":"crossref","unstructured":"Catalan A, Salazar de Pablo G, Serrano, JV, et\u00a0al. Annual research review: prevention of psychosis in adolescents\u2014systematic review and meta-analysis of advances in detection, prognosis and intervention [published online ahead of print 14 September 14, 2020]. J Child Psychol Psychiatry. https:\/\/doi.org\/10.1111\/jcpp.13322","DOI":"10.1111\/jcpp.13322"},{"key":"10.1016\/j.jaac.2021.05.025_bib6","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamapsychiatry.2020.1634","article-title":"Attenuated psychosis syndrome of \u201cpharmacologically attenuated first episode psychosis? An undesirably widespread confounder","volume":"77","author":"Raballo","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2021.05.025_bib7","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.euroneuro.2019.10.006","article-title":"Incidence of adverse events in antipsychotic-naive children and adolescents treated with antipsychotic drugs: results of a multicenter naturalistic study (ETAPE)","volume":"29","author":"Menard","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2021.05.025_bib8","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1017\/S0033291720004237","article-title":"Meta-analyzing the prevalence and prognostic effect\u00a0of\u00a0antipsychotic exposure in clinical high-risk (CHR): when things are not what\u00a0they\u00a0seem","volume":"50","author":"Raballo","year":"2020","journal-title":"Psychol Med"},{"key":"10.1016\/j.jaac.2021.05.025_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2014.01.002","article-title":"Preventing or masking psychosis? Possible unintended consequences of the ultra high-risk strategy","volume":"153","author":"Preti","year":"2014","journal-title":"Schizophr Res"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856721004226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856721004226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:31:21Z","timestamp":1760193081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856721004226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0890856721004226"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2021.05.025","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotics in Children and Adolescents at Clinical High Risk for Psychosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2021.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}